Basel Cell Therapy Symposium
2nd Basel Cell Therapy Symposium
The second edition of the "Basel Cell Therapy Symposium" will take place on January 23rd-24th 2025 at the Biozentrum, Spitalstrasse 41 in Basel .
Save the date and take the opportunity to attend an exciting program of three Sessions and Plenary Lectures held by Yvonne Chen (University of California, LA, USA), Marcela Maus (Harvard Medical School, MA, USA) and Andreas Mackensen (University Erlangen-Nürnberg and University Hospital Erlangen, DE).
The program will be available soon. Check this page regularly for updates.
1st Basel Cell Therapy Symposium
Welcome to the 1st Basel Cell Therapy Symposium:
This one-day symposium, organized by the Innovation Focus Cell Therapies(zelltherapien@usb.ch) of the University Hospital Basel, is taking place on November 9th, 2023.
Event Location: Pullman Basel Europe Hotel, Clarastrasse 43, 4058 Basel, Switzerland
This meeting aims to gather several leaders in the field of engineered stem cells and cellular immunotherapy and to foster interaction and exchange of scientific ideas among clinicians, scientists, and other stakeholders in the field.
The program will feature three sessions focused on non-engineered lymphocytes, engineered lymphocytes, and engineered stem cells, a poster session and two keynote speakers:
John Haanen
is a medical oncologist, director of the Center for Cellular Therapy at the Netherlands Cancer Institute in Amsterdam and a pioneer in innovative immunotherapies. His current research spreads over development of cellular therapies for solid tumors, neoadjuvant immunotherapies and biomarker research.
Waseem Qasim
is a paediatric immunologist and professor of cell and gene therapy at the UCL GOS Institute of Child Health in London. He has led bench-to-bedside development of translational gene therapies, including first-in-human trials of T cells engineered to express chimeric antigen receptors, recombinant T cell receptors & suicide genes.
We look forward to welcome you to the Basel Cell Therapy Symposium.
The Team of the Innovation Focus Cell Therapies:
Andreas Holbro, Lukas Jeker, Nina Khanna, Heinz Läubli
Speakers
Program
Program Overview
-
7.45 Registration
- 8.10-8.20 Welcome and opening
Keynote Lecture 1 chaired by Heinz Läubli
- John Haanen "Understanding TIL therapy for the treatment of metastatic melanoma"
Session 1: "Non-engineered lymphocytes" chaired by Nina Khanna
- Introduction to the session
- Alexandre Harari "Clonotypes dynamics during adoptive cell transfer in cancer patients"
- Patrizia Comoli "Update on multivirus-specific T cell therapies"
- Mohammed Javeed Ansari "Virus-specific T cell Therapy for Treatment of BK virus infection in kidney transplant recipients"
- David König "Adoptive cell therapy with tumor-infiltrating lymphocytes and ANV419. Interim results of the phase I BaseTIL-03M trial"
- Denis Strobbe "Profiling of Epstein-Barr Virus-Specific T Cells in TSCM-enriched Immune Therapy"
- 10.45-11.15 Coffee Break and Poster Session
Keynote Lecture 2 chaired by Lukas Jeker
- Waseem Qasim "Genome edited allo-CAR T trials"
- 12.00-14.00 Lunch and Poster Session
Session 2: "Engineered lymphocytes" chaired by Andreas Holbro
- Introduction to the session
- Maria Themeli "Next generation CAR T cells: combining targets, costimualtion and logic gating"
- Michael Hudecek "Novel targets and technologies for CAR T cells"
- Melita Irving "Coengineering safety and function into T cells for cancer immuno- therapy"
- Gregor Hutter "Enhancing glioblastoma clearance: Empowering anti-EGFRvIII CAR T cells with a paracrine SIRPγ-derived CD47 blocker"
- Raphaël Porret "Redirecting TCR specificity in regulatory T cells toward class I HLA-restricted islet antigens"
- 15.40-16.10 Coffee Break and Poster Session
Session 3: "Engineered stem cells and access to therapy" chaired by Jakob Passweg
- Introduction to the session
- Selim Corbacioglu "Curative treatment options for sicke cell disease and trans-fusion -dependent thalassemia"
- Lukas Jeker "Molecular Cell Shielding - A Therapeutic Platform Approach for Hematologic Diseases"
- Claire Booth "Access to gene therapy for rare diseases"
- Astrid Beerlage "Base Edited HSPCs are Shielded from Targeted CD33 Therapy but Preserve CD33 Expression"
- Amiq Gazdhar "Secretome of Induced pluripotent stem cells for lung repair and regeneration"
- 17.50-17.55 Closing remark
The Symposium will take place in person at the Pullman Basel Europe Hotel Clarastrasse 43, 4058 Basel, Switzerland. All contributions will be in English.
Credits
SGMO: 8 credits
SGH SSH: 8 credits
SSI: 5 credits
Registration
Registration deadline for abstract submission: September15th, 2023
Registration deadline for the symposium (subject to availability): October15th, 2023
Venue
Pullman Basel Europe Hotel,
Clarastrasse 43, 4058 Basel, Switzerland
GPS:47.563069, 7.59784
Tel. : +41 61 690 80 80
Access to hotel
By Car:
- Coming from the north, take motorway exit 1, Basel-Kleinhüningen.
- Coming from the south take motorway exit 2, Badischer Bahnhof.
- Follow the signs to Parkhaus Europe or Hotel Pullman Basel Europe.
By plane:
- From the EuroAirport Basel-Mulhouse, take bus no. 50 to the SBB railway station, then continue with streetcar line 1 (towards Badischer Bahnhof) or line 2 (towards Eglisee) to the Messeplatz stop. The total journey time from the airport is approx. 30 minutes. From Messeplatz follow Clarastrasse to the hotel (approx. one minute walk).
By train and streetcar:
- From Badischer Bahnhof, take streetcar line 2 (direction Binningen) to the Messeplatz stop or line 6 (direction Allschwil) to the Clarastrasse stop.
- From the SBB station, take streetcar line 1 (direction Badischer Bahnhof) or 2 (direction Eglisee) to the Messeplatz stop.
- From Messeplatz follow Clarastrasse to the hotel (approx. one minute walk.)
Contact
Do not hesitate to contact us for any questions via E-Mail zelltherapien@usb.ch
Contributors
Please, note that updates will be regularly made.
The Innovation Focus Cell Therapies of the USB thanks all the supporters who helped us in organizing the Symposium.